Hong Kong Stock Afternoon Review | The Hang Seng Index fell 0.18% in early trading, and the biomedical sector was strong

The Zhitong Finance App learned that the Hong Kong Stock Hang Seng Index fell 0.18% to 41 points to 23,241 points; the Hang Seng Technology Index fell 0.58%. Hong Kong stocks traded HK$111.4 billion in early trading.

Pharmaceutical stocks strengthened in early trading, and a number of major data will soon be unveiled at the ASCO conference. Innovative drug BD boosts industry prosperity. Junshi Biotech (01877) rose 6%; Lepu Bio-B (02157) rose 8%; Kingsley Biotech (01548) rose 5%; and Pharmaceutical Syndicate (02268) rose 5%.

Wayu-B (02256) rose more than 2%, and ipagotinib was approved by the CDE and recognized as a breakthrough treatment for HCC.

Yiming Onko-B (01541) rose by more than 4%, and the IMM2510/AXN-2510 combined chemotherapy phase II trial results are expected to be announced in the second half of the year.

Zhongan Online (06060) rose more than 5%, and its stock price increased by more than 30% during the month. The company is expected to benefit from the Hong Kong Stablecoin Act.

SMORE International (06969) has increased by more than 7%, and Glo Hilo, a next-generation heating product that does not burn, will be launched in Japan.

Inspur Digital Enterprise (00596) rose more than 7%. The company is a leading enterprise in the ERP field in China, and the agency said its valuation was seriously underestimated compared to its peers.

Gu Ming (01364) rose more than 7% to a new high. It is expected to enter the Hong Kong Stock Connect next month. The company's same-store growth was significant in the first quarter.

KEEP (03650) rose more than 7%, and the company's smart sports watch is about to launch, making a major upgrade to the AI running private education function.

Jacochen Pharmaceuticals (02633) rose more than 5%, and net profit for the 2025 fiscal year is expected to increase by more than 10% year-on-year.

Horizon Robot-W (09660) rose 9%, and the company was transferred to the Hong Kong Stock Exchange under the Shenzhen-Hong Kong Stock Exchange. The number of institutional chip shipments is expected to increase year by year.

Giant Biotech (02367) fell more than 2%, and its brand Ke Fumei fell into a “fraud trap”, and Citibank is concerned that its 618 promotional performance will be damaged.